#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15656	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2015	766.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1694	1694	T	894	T,C	816,22	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15656	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2015	766.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1428	1428	C	910	C	879	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29186	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3684	785.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1638	1638	A	994	A,G	938,29	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29186	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3684	785.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2272	2272	C	873	C,T,A	836,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29186	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3684	785.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2346	2346	A	887	A	862	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29186	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3684	785.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2898	2898	C	890	C,G	867,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1968	folP	855	855	100.0	folP.l15.c17.ctg.1	1476	131.6	1	SNP	p	R229S	1	.	.	685	687	AGC	965	967	AGC	199;204;202	A;G,T;C	194;197,1;193	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5394	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3516	152.2	1	SNP	p	S91F	1	.	.	271	273	TTC	716	718	TTC	180;179;178	T;T;C	174;175;174	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5394	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3516	152.2	1	SNP	p	G95N	0	.	.	283	285	GGC	728	730	GGC	175;173;168	G;G;C	168;166;163	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5394	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3516	152.2	1	SNP	p	D95G	1	.	.	283	285	GGC	728	730	GGC	175;173;168	G;G;C	168;166;163	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1706	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1387	122.0	1	SNP	p	G45D	0	.	.	133	135	GGC	472	474	GGC	202;200;200	G;G;C	197;196;192	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	902	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1090	81.6	0	.	n	.	0	A197.	DEL	197	197	A	673	673	A	197	A	192	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4664	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3043	152.1	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1506	1508	GTC	168;167;165	G;T;C	164;160;163	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4664	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3043	152.1	1	SNP	p	D86N	0	.	.	256	258	GAC	612	614	GAC	162;163;167	G;A;C	159;157;163	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4664	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3043	152.1	1	SNP	p	R87I	0	.	.	259	261	CGT	615	617	CGT	169;171;171	C;G;T,G	164;167;164,1	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4664	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3043	152.1	1	SNP	p	R87W	0	.	.	259	261	CGT	615	617	CGT	169;171;171	C;G;T,G	164;167;164,1	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4664	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3043	152.1	1	SNP	p	S87R	1	.	.	259	261	CGT	615	617	CGT	169;171;171	C;G;T,G	164;167;164,1	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4664	parC	2304	2304	99.87	parC.l6.c4.ctg.1	3043	152.1	1	SNP	p	S88P	0	.	.	262	264	TCC	618	620	TCC	171;174;173	T;C;C	163;168;167	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4284	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2543	166.5	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1290	1292	TGC	182;183;183	T,C;G;C	172,4;180;180	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4284	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2543	166.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1500	1502	GGC	192;191;188	G;G;C	186;185;180	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	4228	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2305	179.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1195	1197	GCA	230;232;232	G;C;A,C	219;218;220,3	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4228	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2305	179.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1198	1200	ATC	232;232;230	A;T;C,G	220;222;213,3	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4228	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2305	179.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1210	1212	GTG	220;218;218	G,A;T,C;G,C	211,1;210,1;208,1	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4228	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2305	179.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1210	1212	GTG	220;218;218	G,A;T,C;G,C	211,1;210,1;208,1	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4228	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2305	179.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1714	1716	ACC	210;211;213	A;C;C	193;202;201	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4228	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2305	179.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1768	1770	GCG	179;176;178	G;C,G;G	167;149,2;166	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4228	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2305	179.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1768	1770	GCG	179;176;178	G;C,G;G	167;149,2;166	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4228	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2305	179.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1891	1893	GGC	177;178;177	G;G;C,T	169;172;168,2	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4228	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2305	179.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1900	1902	GGC	173;173;170	G,A;G;C	161,2;164;163	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4228	penA	1749	1749	99.94	penA.l15.c17.ctg.1	2305	179.8	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1918	1920	TCG	151;154;155	T,G,C;CG,CGG;G,C	91,21,2;127,1;136,1	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6252	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3054	203.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1600	1602	CCG	219;216;218	C,G;C;G,C	207,1;207;199,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2428	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1878	127.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	524	524	C	172	C,T	161,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3188	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1366	229.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	286	288	GAA	239;239;236	G;A;A	228;230;229	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3188	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1366	229.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	574	576	GAT	253;256;260	G,A;A;T,C	231,16;246;252,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3188	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1366	229.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	697	699	TCA	281;277;278	T;C;A	275;272;270	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3188	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1366	229.0	0	.	p	.	0	F215L	NONSYN	643	645	TTT	817	819	CTT	241;239;241	C;T;T	230;232;234	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3188	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1366	229.0	0	.	p	.	0	A218I	NONSYN	652	654	GCC	826	828	ATC	259;261;260	A;T,A;C	249;250,1;252	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3188	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1366	229.0	0	.	p	.	0	F222L	NONSYN	664	666	TTT	838	840	CTT	264;269;272	C,T;T;T	242,10;251;258	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3188	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1366	229.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1156	1158	GCA	251;252;252	G;C,A;A	239;233,6;240	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3188	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1366	229.0	1	SNP	p	G120K	1	.	.	358	360	AAG	532	534	AAG	271;273;273	A;A;G	260;262;262	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3188	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1366	229.0	1	SNP	p	A121D	1	.	.	361	363	GAC	535	537	GAC	274;274;276	G,A;A;C	250,11;262;268	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3188	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1366	229.0	1	SNP	p	D121N	0	.	.	361	363	GAC	535	537	GAC	274;274;276	G,A;A;C	250,11;262;268	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	342	porB3	990	116	92.24	porB3.l15.c30.ctg.2	355	32.5	0	.	p	.	0	M18T	NONSYN	52	54	ATG	224	226	ACG	64;64;58	A;C;G	60;60;55	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	342	porB3	990	116	92.24	porB3.l15.c30.ctg.2	355	32.5	0	.	p	.	0	T29A	NONSYN	85	87	ACC	257	259	GCC	47;43;37	G;C;C	42;39;35	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	342	porB3	990	116	92.24	porB3.l15.c30.ctg.2	355	32.5	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	266	268	CAA	24;24;23	C;A;A	23;23;22	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	342	porB3	990	116	92.24	porB3.l15.c30.ctg.2	355	32.5	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	272	274	TAC	16;13;12	T;A;C	15;13;12	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11748	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4732	245.9	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1924	1926	AAT	241;241;242	A,C;A;T	231,4;232;232	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1322	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	895	144.8	1	SNP	p	V57M	1	.	.	169	171	ATG	482	484	ATG	257;257;256	A;T;G	252;251;252	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
